CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +325.9% | +2,511.9% | -19.1% | -27.9% | -33.8% | -26.8% | +7.2% | +168.7% | +51.1% | +73.1% | +36.9% | -30.6% | +104.7% | -29.2% | +85.9% | +71.2% | +23.6% | +58.0% | +25.2% | +81.1% | +30.0% | |
| – | – | – | +319.5% | +2,568.3% | -19.7% | -27.9% | -33.8% | -26.8% | +7.8% | +168.6% | +51.4% | +73.1% | +36.7% | -30.8% | +105.5% | -35.2% | +101.8% | +43.0% | +31.9% | +52.7% | -31.6% | +184.3% | +43.4% | |
| – | – | – | +319.3% | +2,550.0% | -22.0% | -26.2% | -33.9% | -29.6% | +10.1% | -76.6% | +57.2% | +310.5% | +210.4% | -50.8% | +313.9% | -71.2% | +440.5% | +45.5% | +31.6% | +74.0% | -53.9% | +276.0% | +37.0% | |
| – | – | – | +319.3% | +2,550.0% | -22.0% | -26.2% | -33.9% | -29.6% | +10.1% | +155.7% | +53.8% | +65.6% | +48.7% | -30.8% | +107.9% | -36.3% | +76.7% | +48.4% | +36.3% | +56.0% | -53.9% | +276.0% | +37.0% | |
| – | – | – | – | – | -25.7% | -80.9% | – | – | – | – | – | – | – | – | – | – | – | -43.2% | +12.3% | +60.5% | +395.8% | +22.4% | +95.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +3,393.5% | +137.7% | +69.2% | -13.5% | +129.9% | +24.9% | +90.2% | |
| – | – | – | +300.0% | +400.0% | +540.0% | -25.0% | -29.2% | -33.8% | -72.9% | +340.5% | -24.3% | +75.7% | +168.4% | +27.5% | -21.6% | +28.2% | -14.2% | -38.3% | +2,963.2% | -78.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +497.6% | -19.3% | -16.0% | |
| – | – | – | +405.9% | +125.3% | -53.8% | +312.3% | -76.3% | -10.0% | +693.3% | -12.9% | +83.6% | +117.8% | -46.6% | -48.2% | +84.5% | +118.5% | +156.0% | -8.0% | +36.0% | +142.9% | +9.3% | +50.5% | +23.2% | |
| – | – | – | +405.9% | +125.3% | -60.8% | +371.5% | -79.4% | +1.6% | +178.9% | +97.5% | +29.9% | +173.6% | -41.2% | -39.1% | +103.7% | +122.9% | +153.4% | -5.6% | +18.9% | +112.8% | +32.1% | +58.7% | +21.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -90.3% | +962.1% | +9.4% | +9.5% | +8.9% | +8.7% | |
| – | – | – | +120.4% | +561.3% | -50.9% | +51.3% | -25.0% | -57.6% | +149.2% | +417.4% | -37.7% | +113.2% | -1.1% | -48.0% | +108.5% | +20.1% | +76.2% | +3.4% | -35.0% | +43.6% | +272.2% | +12.2% | -32.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +279.7% | +4,345.3% | -17.8% | -35.3% | -27.9% | -27.6% | -31.8% | +288.8% | +46.3% | +64.8% | +57.4% | -29.1% | +106.0% | -37.3% | +72.6% | +93.5% | +22.0% | +45.2% | +29.1% | +87.6% | +31.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +143.2% | +135.1% | +66.3% | |
| – | +23.7% | +0.0% | +112.6% | +23.9% | +62.9% | +3.9% | +15.8% | +23.3% | +16.9% | +38.2% | +51.3% | +41.1% | +26.1% | +2.5% | +3.5% | +19.6% | +3.3% | +0.2% | +1.5% | +3.3% | +2.1% | +9.8% | +1.9% |
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.